|
AHICE
Active Immune-Cancertherapy by treatment with Autologous produced Human Immune-mediators / Cytokines and related Immune-Effectors.
Specified active Carcinoma-immune-therapy AHICE
with the whole human immune-mediators-caskade
(interferons, interleukines, tumour-necrosis-factor-alpha and related Immune Effectors) autologous synthesized - it means, produced from patient´s own blood. Medical Information Autologous Human
Immune-mediators / Cytokines and related Immune Effectors AHICE, like
other autologous blood products, are advantageous in that they carry no risks of viral infection, like Hepatites B or C or HIV (AIDS) and that allergic reactions are still not known. The aktive Immune-Tumourtherapy
AHICET is of high specificity against tumour- and their metastatic-cells.
Their autologous production is initiated on in a specific treatment in our biomolecular lab – patent . This means, that patient´s own immune-apparatous will get a specific information about the altered shape of the tumourcells and is thereafter able to identify them as none healthy bodycells. After that, the immune-apparatous, as the most
intelligent, unique physiological “antigen-searching
pharmacon” starts to kill the so identified tumourcells via antigen-specific
activation of the natural killer cells(NKs) and the cytotoxic T-Lymphocyte-Cells(CTLs). This is a highly specific, but very complexed immunological / biochemical mechanism. Thereafter, it is the greatest benefit, that the patient´s own immune-system can so identify and eliminate the altered tumourcells, not only
in the site of solid tumour, but in the metastatic sites everywhere in the whole patient´s organism.
|
